Europe Views

Pages

NICE Recommends Sovaldi

NICE's preliminary recommendation of Sovaldi for the most common types of hepatitis C has strengthened Gilead's case for premium pricing. Having convinced the most stringent regulator in Europe, the...

Read article ›

Pages